SELLAS LIFE SCIENCES GROUP I - COM (SLS)

CUSIP: 81642T100

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
12,866,806
Share change
+9,239,041
Total reported value
$1,446,002
Price per share
$0.11
Number of holders
15
Value change
+$1,037,836
Number of buys
11
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 81642T100?
CUSIP 81642T100 identifies SLS - SELLAS LIFE SCIENCES GROUP I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SELLAS LIFE SCIENCES GROUP I - COM (SLS) as of Q2 2019

As of 30 Jun 2019, SELLAS LIFE SCIENCES GROUP I - COM (SLS) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,866,806 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, 683 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, VANGUARD GROUP INC, Anson Funds Management LP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and MORGAN STANLEY. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.